Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 17 10:31AM ET
1.34
Dollar change
+0.12
Percentage change
9.84
%
Index- P/E- EPS (ttm)-0.37 Insider Own36.65% Shs Outstand44.21M Perf Week-4.29%
Market Cap59.24M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float28.01M Perf Month-14.65%
Income-15.55M PEG- EPS next Q- Inst Own11.73% Short Float18.70% Perf Quarter-52.82%
Sales9.13M P/S6.49 EPS this Y- Inst Trans-5.75% Short Ratio19.07 Perf Half Y-46.18%
Book/sh0.43 P/B3.13 EPS next Y- ROA-48.44% Short Interest5.24M Perf Year2.29%
Cash/sh0.34 P/C3.97 EPS next 5Y- ROE-61.54% 52W Range1.21 - 7.01 Perf YTD-56.77%
Dividend Est.- P/FCF- EPS past 5Y-60.64% ROI-75.19% 52W High-80.88% Beta1.50
Dividend TTM- Quick Ratio1.85 Sales past 5Y- Gross Margin53.64% 52W Low10.74% ATR (14)0.10
Dividend Ex-Date- Current Ratio2.39 EPS Y/Y TTM20.94% Oper. Margin-171.91% RSI (14)38.13 Volatility5.87% 5.97%
Employees- Debt/Eq0.01 Sales Y/Y TTM32.02% Profit Margin-170.32% Recom3.00 Target Price2.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q25.82% Payout- Rel Volume2.04 Prev Close1.22
Sales Surprise- EPS Surprise- Sales Q/Q113.46% EarningsMar 28 AMC Avg Volume274.58K Price1.34
SMA20-8.56% SMA50-20.00% SMA200-43.94% Trades Volume111,153 Change9.84%
Date Action Analyst Rating Change Price Target Change
Jan-25-22Downgrade Maxim Group Buy → Hold
May-03-21Initiated Ladenburg Thalmann Buy $26.50
Apr-15-21Initiated Maxim Group Buy $11
May-24-24 01:29PM
Apr-26-24 09:16AM
Apr-19-24 05:28PM
Apr-15-24 09:05AM
Apr-01-24 09:05AM
09:05AM Loading…
Mar-25-24 09:05AM
Mar-07-24 09:05AM
Mar-05-24 09:05AM
Feb-08-24 09:05AM
Feb-05-24 09:05AM
Jan-16-24 09:05AM
Dec-27-23 09:05AM
Dec-06-23 09:05AM
Nov-21-23 09:05AM
Nov-10-23 01:07PM
04:05PM Loading…
Nov-09-23 04:05PM
Nov-01-23 12:00PM
Oct-26-23 09:05AM
Oct-24-23 09:05AM
Oct-16-23 09:05AM
Oct-13-23 09:05AM
Oct-05-23 09:05AM
Sep-28-23 04:05PM
Sep-15-23 10:00AM
Aug-31-23 09:05PM
Aug-09-23 04:05PM
Aug-03-23 09:05AM
Jul-27-23 09:05AM
Jul-26-23 09:05AM
Jul-20-23 09:05AM
09:05AM Loading…
Jul-13-23 09:05AM
Jul-06-23 12:10PM
Jun-30-23 08:05AM
Jun-27-23 09:05AM
Jun-15-23 09:05AM
Jun-07-23 09:05AM
Jun-01-23 09:05AM
May-30-23 09:05AM
May-26-23 02:30PM
May-10-23 04:05PM
May-03-23 08:15AM
Apr-26-23 08:15AM
Apr-17-23 05:00PM
Mar-17-23 08:15AM
Mar-01-23 04:05PM
Feb-15-23 08:15AM
Feb-14-23 08:15AM
Feb-08-23 08:15AM
Feb-07-23 08:15AM
Jan-31-23 04:05PM
08:15AM
Jan-19-23 08:15AM
Jan-11-23 08:15AM
Nov-30-22 09:05AM
Nov-12-22 07:22AM
Nov-09-22 04:05PM
04:03PM
Oct-26-22 09:05AM
Oct-13-22 09:05AM
Sep-20-22 04:05PM
Sep-14-22 09:05AM
Aug-24-22 09:05AM
Aug-11-22 01:27PM
Aug-10-22 04:02PM
04:01PM
Jul-29-22 09:05AM
Jul-28-22 09:10AM
Jul-25-22 09:05AM
Jul-21-22 08:57AM
Jul-19-22 09:07AM
Jul-06-22 09:03AM
Jun-28-22 09:05AM
Jun-23-22 09:48AM
Jun-22-22 11:00AM
Jun-15-22 09:04AM
Jun-07-22 08:52AM
May-26-22 08:52AM
May-23-22 08:52AM
May-09-22 09:07AM
May-03-22 04:01PM
Apr-25-22 10:30AM
08:50AM
Apr-18-22 09:00AM
09:00AM
Mar-23-22 01:15PM
Mar-21-22 05:01PM
Mar-10-22 04:02PM
Mar-08-22 12:57PM
Mar-01-22 09:04AM
Jan-31-22 09:12AM
Jan-24-22 08:00AM
Jan-20-22 09:47AM
Jan-19-22 09:18AM
Jan-13-22 09:08AM
Jan-11-22 09:47AM
Jan-10-22 09:17AM
Jan-06-22 09:03AM
Jan-05-22 09:12AM
Jan-04-22 09:48AM
Jan-03-22 11:00AM
Wrap Technologies, Inc. is a global public safety technology and service company, which engages in the provision of modern policing solutions to law enforcement and security personnel. Its products include BolaWrap Remote Restraint Device and Wrap Reality. The company was founded by Elwood G. Norris, Scot J. Cohen, and James A. Barnes in March 2016 and is headquartered in Tempe, AZ.
Last Close
Jun 17 10:31AM ET
0.4200
Dollar change
+0.0045
Percentage change
1.08
%
Index- P/E- EPS (ttm)-6.21 Insider Own12.51% Shs Outstand7.00M Perf Week-10.64%
Market Cap2.94M Forward P/E- EPS next Y-3.26 Insider Trans0.00% Shs Float6.12M Perf Month-23.37%
Income-13.04M PEG- EPS next Q- Inst Own0.92% Short Float2.53% Perf Quarter-71.43%
Sales6.98M P/S0.42 EPS this Y38.07% Inst Trans0.74% Short Ratio0.30 Perf Half Y-69.57%
Book/sh1.42 P/B0.30 EPS next Y19.51% ROA-33.16% Short Interest0.15M Perf Year-83.91%
Cash/sh1.58 P/C0.27 EPS next 5Y- ROE-91.54% 52W Range0.38 - 4.74 Perf YTD-70.21%
Dividend Est.- P/FCF- EPS past 5Y- ROI-76.03% 52W High-91.14% Beta2.33
Dividend TTM- Quick Ratio1.46 Sales past 5Y-14.44% Gross Margin17.66% 52W Low9.09% ATR (14)0.07
Dividend Ex-Date- Current Ratio1.60 EPS Y/Y TTM- Oper. Margin-140.66% RSI (14)33.27 Volatility13.44% 12.24%
Employees21 Debt/Eq0.75 Sales Y/Y TTM- Profit Margin-186.72% Recom1.00 Target Price4.00
Option/ShortNo / Yes LT Debt/Eq0.60 EPS Q/Q17.02% Payout- Rel Volume1.72 Prev Close0.42
Sales Surprise-121.14% EPS Surprise-125.23% Sales Q/Q74.01% EarningsFeb 28 Avg Volume520.71K Price0.42
SMA20-23.68% SMA50-34.76% SMA200-67.02% Trades Volume177,725 Change1.08%
May-29-24 09:00AM
May-21-24 09:15AM
May-16-24 10:53AM
May-14-24 09:15AM
07:00AM
10:20AM Loading…
Apr-25-24 10:20AM
Apr-23-24 09:15AM
Apr-16-24 09:15AM
Apr-02-24 09:53AM
09:15AM
Mar-19-24 09:00AM
Mar-11-24 07:00AM
Feb-14-24 09:15AM
Jan-24-24 09:15AM
Jan-17-24 09:00AM
10:00AM Loading…
Dec-12-23 10:00AM
09:15AM
Dec-05-23 09:15AM
Oct-30-23 09:15AM
Oct-19-23 09:00AM
Oct-04-23 09:00AM
Sep-28-23 08:00AM
Sep-11-23 09:00AM
Sep-06-23 04:05PM
Jul-13-23 04:30PM
Nov-30-22 12:45PM
Nov-15-22 08:00AM
Oct-25-22 09:00AM
Oct-21-22 08:00AM
Aug-15-22 08:00AM
10:27AM Loading…
Jul-28-22 10:27AM
09:25AM
Jul-19-22 09:15AM
May-16-22 05:00PM
May-03-22 09:23AM
Apr-27-22 09:25PM
09:00AM
Apr-26-22 09:15AM
Apr-19-22 09:15AM
Apr-01-22 07:00AM
Mar-03-22 08:00AM
Feb-01-22 09:15AM
Jan-24-22 09:15AM
Jan-18-22 09:20AM
Jan-06-22 04:30PM
Jan-05-22 01:38PM
Dec-28-21 09:15AM
Dec-22-21 09:10AM
Dec-08-21 09:15AM
Dec-02-21 12:00PM
Nov-30-21 09:00AM
Nov-15-21 04:30PM
Nov-11-21 09:15AM
Nov-08-21 09:15AM
Nov-03-21 09:16AM
Oct-21-21 09:25AM
Oct-19-21 09:25AM
Oct-14-21 09:00AM
Sep-23-21 08:30AM
Sep-10-21 08:30AM
Aug-17-21 09:25AM
Aug-16-21 08:30AM
Aug-12-21 08:00AM
Aug-11-21 10:39AM
Jul-27-21 09:25AM
Jul-13-21 09:15AM
Jul-12-21 08:15AM
Jun-02-21 10:12AM
May-17-21 08:22AM
May-14-21 08:30AM
May-07-21 08:00AM
Mar-18-21 09:00AM
Feb-18-21 08:00AM
Feb-04-21 08:30AM
Jan-19-21 08:00AM
Dec-08-20 04:15PM
Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, a FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie's disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.
Last Close
Jun 17 10:30AM ET
4.52
Dollar change
-0.09
Percentage change
-1.95
%
Index- P/E- EPS (ttm)-37.21 Insider Own2.14% Shs Outstand1.23M Perf Week8.65%
Market Cap5.56M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.21M Perf Month-7.94%
Income-12.23M PEG- EPS next Q- Inst Own3.97% Short Float1.75% Perf Quarter-8.22%
Sales0.00M P/S- EPS this Y- Inst Trans-61.94% Short Ratio0.44 Perf Half Y-35.91%
Book/sh20.32 P/B0.22 EPS next Y- ROA-13.75% Short Interest0.02M Perf Year-80.68%
Cash/sh22.98 P/C0.20 EPS next 5Y- ROE-16.94% 52W Range3.53 - 47.00 Perf YTD-33.50%
Dividend Est.- P/FCF- EPS past 5Y8.59% ROI-55.44% 52W High-90.38% Beta1.49
Dividend TTM- Quick Ratio4.58 Sales past 5Y0.00% Gross Margin- 52W Low28.14% ATR (14)0.28
Dividend Ex-Date- Current Ratio4.58 EPS Y/Y TTM-145.64% Oper. Margin0.00% RSI (14)51.06 Volatility5.73% 5.56%
Employees8 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price350.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q93.78% Payout- Rel Volume0.64 Prev Close4.61
Sales Surprise- EPS Surprise21.82% Sales Q/Q- Earnings- Avg Volume48.41K Price4.52
SMA200.78% SMA50-2.01% SMA200-26.42% Trades Volume6,054 Change-1.95%
May-20-24 11:54AM
May-07-24 09:00AM
Apr-24-24 09:15AM
Apr-09-24 09:15AM
Apr-03-24 08:00AM
09:00AM Loading…
Dec-19-23 09:00AM
Dec-06-23 09:00AM
Nov-02-23 09:00AM
Sep-26-23 09:00AM
Sep-07-23 09:00AM
Jul-19-23 09:00AM
Jul-13-23 09:00AM
Mar-07-23 09:00AM
Dec-16-22 09:00AM
Nov-18-22 09:00AM
09:00AM Loading…
Oct-19-22 09:00AM
Sep-28-22 11:50AM
Aug-12-22 09:00AM
Jul-26-22 09:15AM
Jul-21-22 09:15AM
Jul-20-22 09:15AM
May-17-22 09:15AM
Apr-19-22 09:15AM
Apr-05-22 09:15AM
Mar-29-22 09:15AM
Mar-22-22 09:15AM
Mar-15-22 09:15AM
Feb-23-22 09:15AM
Feb-07-22 09:38AM
Feb-01-22 09:15AM
11:58AM Loading…
Dec-06-21 11:58AM
Sep-28-21 09:00AM
Sep-10-21 09:00AM
Aug-05-21 10:00AM
Jul-26-21 09:15AM
Jul-21-21 09:00AM
Jul-14-21 09:00AM
Jul-07-21 09:00AM
Jun-24-21 09:00AM
Jun-14-21 09:00AM
Jun-09-21 09:00AM
05:38AM
May-19-21 09:00AM
May-10-21 09:00AM
Apr-26-21 09:00AM
Apr-01-21 09:00AM
Mar-05-21 09:00AM
Feb-25-21 09:12AM
Feb-12-21 09:00AM
Feb-09-21 09:00AM
Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer's disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson's Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.
Last Close
Jun 17 10:31AM ET
2.53
Dollar change
+0.01
Percentage change
0.40
%
Index- P/E- EPS (ttm)-5.93 Insider Own1.93% Shs Outstand4.18M Perf Week41.34%
Market Cap10.58M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.10M Perf Month40.17%
Income-24.74M PEG- EPS next Q- Inst Own7.20% Short Float1.56% Perf Quarter32.11%
Sales31.77M P/S0.33 EPS this Y- Inst Trans- Short Ratio3.97 Perf Half Y19.91%
Book/sh2.53 P/B1.00 EPS next Y- ROA-49.45% Short Interest0.06M Perf Year-50.26%
Cash/sh4.57 P/C0.55 EPS next 5Y20.00% ROE-108.94% 52W Range1.26 - 6.40 Perf YTD45.40%
Dividend Est.- P/FCF- EPS past 5Y66.28% ROI-123.11% 52W High-60.47% Beta2.47
Dividend TTM- Quick Ratio2.57 Sales past 5Y124.62% Gross Margin12.99% 52W Low100.79% ATR (14)0.17
Dividend Ex-Date- Current Ratio2.66 EPS Y/Y TTM23.38% Oper. Margin-46.37% RSI (14)80.20 Volatility17.67% 8.87%
Employees337 Debt/Eq1.15 Sales Y/Y TTM-18.44% Profit Margin-77.88% Recom1.00 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq0.90 EPS Q/Q54.57% Payout- Rel Volume3.03 Prev Close2.52
Sales Surprise1.23% EPS Surprise0.00% Sales Q/Q23.55% EarningsApr 16 AMC Avg Volume16.06K Price2.53
SMA2042.59% SMA5049.19% SMA20028.35% Trades Volume9,678 Change0.40%
Today 08:00AM
Jun-05-24 08:00AM
May-23-24 08:00AM
May-15-24 11:52PM
04:30PM
08:00AM Loading…
May-02-24 08:00AM
Apr-19-24 09:00AM
Apr-17-24 08:48AM
Apr-16-24 11:52PM
04:30PM
08:00AM
Apr-01-24 04:30PM
Mar-12-24 07:01AM
Feb-14-24 08:00AM
Jan-04-24 08:00AM
04:15PM Loading…
Dec-15-23 04:15PM
Dec-11-23 08:00AM
Nov-15-23 08:00AM
Nov-14-23 04:30PM
Nov-06-23 07:06AM
07:00AM
Oct-11-23 08:00AM
Oct-09-23 08:00AM
Oct-02-23 08:00AM
Sep-28-23 09:00AM
Sep-27-23 08:00AM
Sep-19-23 08:00AM
Sep-12-23 04:30PM
Aug-19-23 08:02AM
Aug-17-23 08:08AM
06:23AM Loading…
Aug-15-23 06:23AM
Aug-14-23 04:30PM
Aug-07-23 04:30PM
Jul-20-23 08:00AM
Jul-18-23 04:15PM
Jul-14-23 11:22AM
Jul-13-23 08:00AM
May-16-23 05:54AM
May-15-23 04:30PM
May-11-23 12:39PM
08:00AM
May-04-23 08:00AM
May-03-23 08:00AM
Apr-27-23 04:15PM
Apr-19-23 03:54PM
Apr-18-23 06:35AM
Apr-17-23 04:15PM
Apr-14-23 05:05PM
Mar-30-23 04:30PM
Mar-22-23 08:00AM
Jan-31-23 08:00AM
Jan-17-23 08:00AM
Dec-20-22 09:11AM
Dec-12-22 08:00AM
Dec-05-22 08:00AM
Nov-16-22 05:20AM
Nov-10-22 04:00PM
Nov-09-22 08:00AM
Nov-07-22 08:00AM
Nov-03-22 06:00PM
Nov-02-22 04:00PM
XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Naples Wax Center, Treat, and Corporate & Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Naples Wax Center segment is focused on the products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.